Tag: DCB

Boston Scientific’s Agent DCB gains first US FDA coronary approval

Boston Scientific has announced that it has received US Food and Drug Administration (FDA) approval ...

Latest-generation DCBs “change thinking” on treatment of coronary artery disease

 Interventional cardiologists need to have a range of approaches and devices in their toolbox to t...

EuroPCR 2023: Biolimus-coated balloon fails to match paclitaxel for in-stent restenosis

Results of the first study of a first-generation drug-coated balloon (DCB) with a biolimus coati...

ADVERTORIAL: Ready for the primetime? The future role of drug-coated balloons in PCI

This advertorial is sponsored by B Braun Melsungen AG “The evolution of PCI has always been a co...

Important to utilise DCBs with strongest possible data behind them

NOTE: This video is ONLY available to watch in selected countries and geographies  Tuomas Ri...

Breakthrough device designation granted for SirPlux Duo coronary DCB in small vessels

Advanced NanoTherapies has been granted US Food and Drug Administration (FDA) breakthrough devic...

Enrolment completed in TRANSFORM 1 trial of MagicTouch DCB

Concept Medical has announced the successful completion of the TRANSFORM 1 RCT. The randomised c...

First patient enrolled in TRANSFORM II study of sirolimus-coated balloon

The first patient has been enrolled in the TRANSFORM II randomised controlled trial assessing th...
everolimus

Cardiovascular Systems and Chansu Vascular Technologies partner to develop new everolimus DCBs

Cardiovascular Systems (CSI) has partnered with Chansu Vascular Technologies (CVT) to develop no...

Paclitaxel coated balloons have lower risk of mortality in coronary arteries at three years than control treatments

Paclitaxel drug coated balloons (DCB) for percutaneous treatment of coronary artery disease (CAD...

Customising therapy in femoropopliteal revascularisation

 Gary Ansel (Columbus, USA) tells Vascular News at VEITHSymposium 2018 about how drug-based ther...
paclitaxel

Meta-analysis finds a higher risk of death in the long term when paclitaxel-coated devices are used in the leg

New data, just published in the Journal of the American Heart Association (JAHA), suggest that t...